Vaxart, Inc. Treasury Stock, Common, Value
Vaxart, Inc. (VXRT) had Treasury Stock, Common, Value of $90.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockCommonValue · last filed 2026-08-06
- 2026-06-30: Treasury Stock, Common, Value $90.00K.
- 2026-03-31: Treasury Stock, Common, Value $497.00K.
- 2025-12-31: Treasury Stock, Common, Value $159.00K.
- 2025-09-30: Treasury Stock, Common, Value $371.00K.
| Period end | Treasury Stock, Common, Value |
|---|---|
| 2026-06-30 | $90.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $497.00K S-1 · filed 2026-05-08 |
| 2025-12-31 | $159.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $371.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $367.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $517.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $350.00K S-1 · filed 2026-05-08 |
| 2024-09-30 | $574.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $565.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $548.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $366.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $39.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $31.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $10.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |